GlaxoSmithKline Pharmaceuticals Limited (BOM: 500660)

GlaxoSmithKline Pharmaceuticals Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 8.15B INR in the quarter ending June 30, 2024, with 6.96% growth. This brings the company's revenue in the last twelve months to 35.07B, up 7.29% year-over-year. In the fiscal year ending March 31, 2024, GlaxoSmithKline Pharmaceuticals had annual revenue of 34.54B with 6.21% growth.

• Revenue (ttm): 35.07B
• Revenue Growth: +7.29%
• P/S Ratio: 13.62
• Revenue / Employee: 10.92M
• Employees: 3,211
• Market Cap: 477.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%
Mar 31, 2021	29.26B	-2.99B	-9.27%
Mar 31, 2020	32.24B	962.62M	3.08%